We produce high-quality plasmid DNA and RNA for various types of RNA drugs (including siRNA), mRNA vaccines and innovative gene and cell therapies. These products open up a new era of medicine and have the potential to revolutionize the pharmaceutical industry. Unmet medical needs become accessible and potentially curative by a one-time treatment.
High quality is guaranteed as cGMP regulations are an integral part of the Novartis comprehensive quality assurance system for bio-pharmaceutical and advanced therapy medicinal products.
The manufacturing process follows your specifications using scalable and standardized processes across a variety of scales for clinical and commercial purposes.